In distinction to the development of the clinical indications for intracranial radiosurgery, spine radiosurgery's initial primary focus was and still remains the treatment of malignant disease. The role of stereotactic radiosurgery for the treatment of intracranial benign tumors has been well established. However, there is much less experience and much more controversy regarding the use of radiosurgery for the treatment of benign tumors of the spine. This study presents the clinical experience and current trends of radiosurgery in the treatment paradigm of benign tumors of the spine as part of a dedicated spine radiosurgery program.
Introduction
Radiation therapy has been used for the treatment of numerous benign diseases since the discovery of the therapeutic potential of ionizing radiation (1) (2) (3) (4) (5) . Stereotactic radiosurgery for the treatment of a wide variety of benign intracranial lesions has become widely accepted with excellent long-term outcomes and minimal toxicity (6-10). Although similar benign tumor histologies can be found in and around the spine, the initial radiosurgical instruments were framebased and unable to treat such extracranial targets (11) . The more recent emergence of frameless image-guided radiosurgery allows for the ability to treat such tumors throughout the body (12) (13) (14) . There is now a substantial body of literature that supports the use of extracranial radiosurgery for the treatment of a variety of malignant spinal tumors (13, (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) . However, there is much less experience and much more controversy regarding the use of radiosurgery for the treatment of benign tumors of the spine.
There are significant differences between benign and malignant tumors of the spine that have affected the adoption of radiosurgery as a treatment modality for these lesions. The primary treatment option for most benign spinal neoplasms is microsurgical resection without adjuvant radiotherapy. The safety and effectiveness of such surgery has been clearly documented (11, (35) (36) (37) (38) (39) (40) . In certain circumstances, however, some patients are less than ideal candidates for open standard surgical resection because of age, medical comorbidities, the recurrent nature of their tumor, or because multiple lesions occur in the setting of one of the family phakomatoses (11). It is in such clinical circumstances that radiosurgery has been explored as a treatment option for these patients. Several recent publications have now documented both the safety as well as the long-term efficacy of radiosurgery for benign spinal tumors (11, 41) . Because patients with such benign lesions have prolonged life expectancies compared to their malignant counterparts, the potential for delayed radiation myelopathy is a special concern. In addition, benign spine tumors have their own unique presentation, relationship to the spinal cord and radiobiologic response to radiosurgery, all of which represent unique challenges to the safe and effective application of radiosurgical ablation (11).
Cone beam computed tomography (CBCT) image guidance technology now has been adapted for radiosurgery setup with delivery by a variety of radiosurgery delivery systems (42, 43) . Following an extensive experience with spine radiosurgery using non-CBCT technologies, our facility began a dedicated spine radiosurgery program using the CBCT image guidance for treatment setup localization (44). This study represents the evaluation of a cohort who underwent radiosurgery for benign tumors of the spine in order to determine a safety profile for a CBCT image guidance technique, to analyze doses used, and to explore future directions for this treatment modality in this patient population.
Materials and Methods
Forty consecutive benign spine tumors underwent radiosurgery treatment and were evaluated under an Institutional Review Board approved protocol investigation. Radiosurgery was offered to patients for whom microsurgical resection was felt to be contraindicated or in cases of strong patient preference. All cases had well-circumscribed lesions, no evidence of spinal instability, and generally minimal compromise of spinal cord function. All patients were carefully followed by a dedicated research nurse using gadolinium enhanced MR imaging at 3, 6, and 12 months and yearly thereafter. Neurologic examination and the occurrence of any toxicity were evaluated in person at each follow up imagining time point or by telephone if necessary.
In 2007, our institution expanded our spine radiosurgery delivery technologies to include computed tomography (CBCT) image guidance for radiosurgery delivery. This acquisition was part of an upgrade of multiple conventional linear accelerators to allow for image guided radiotherapy (IGRT) capability. Our spine radiosurgery program expanded to incorporate and prospectively evaluate CBCT image guided radiosurgery in addition to our extensive experience using the CyberKnife Image-Guided Radiosurgery System (Accuray, Inc., Sunnyvale, CA).
All lesions were treated using the Elekta Synergy S 6-MV linear accelerator with a beam modulator and cone beam computed tomography (CBCT) image guidance combined with a HexaPOD couch that allows patient positioning correction in 3 translational and 3 rotational directions. In a plane orthogonal to the linear accelerator, the CBCT image guidance system is mounted on the gantry. Our technique for utilizing CBCT for radiosurgery image guidance has been described elsewhere (44, 45) . Patients were immobilized with the BodyFix (total body bag, Medical Intelligence ® ) when treatment sites were below T6; otherwise, a head and shoulder mask with S-board (CIVCO, Kalona, IA) was used. The Pinnacle treatment planning system (version 8.0, Pinnacle v.8.0) treatment planning system (Philips, Amsterdam, Netherlands) and a 1.5-mm CT slice thickness were used to plan all spine radiosurgery treatments.
Results
The study cohort included 15 men and 25 women, ages 23 to 88 (mean age 55 years). Table I lists the characteristics of the treatment group. Lesion location included 13 cervical, 9 thoracic, 11 lumbar, and 7 sacral tumors. The most common tumor histologies were schwannoma (15 cases), neurofibroma (7 cases), and meningioma (8 cases). The remaining histologies included ganglioglioma, hemangioma, aneurismal bone cyst, and giant cell tumor. Five patients had previously diagnosed neurofibromatosis. Thirty-four cases (85%) were intradural. Radiosurgery was used as the primary treatment modality in 22 cases (55%) and for recurrence after prior open surgical resection in 18 cases (45%).
Patients reported a significant component of pain in 11 cases (28%). Seven of the patients (18%) had previously implanted titanium instrumentation and/or methylmethacrylate bone cement at the treated level. MR imaging (or CT myelography when the patient could not undergo an MRI) was fused with the planning CT for contouring purposes in all cases if possible. Prescription dosage and fractionation were based on tumor size, volume, location, the degree of potential spinal cord exposure, and history of previous irradiation.
The radiosurgery procedure was successfully completed in all patients. No subacute or long term spinal cord or cauda equina toxicity occurred during the follow-up period (median 26 months, range 6 to 49 months). The mean prescribed dose to the gross tumor volume (GTV) was 14 Gy (range 11 to 17) delivered in a single fraction in 35 cases. In 5 cases in which the tumor was found to be intimately associated with the spinal cord with distortion of the spinal cord itself, the prescribed dose to the GTV was 18 to 21 Gy delivered in 3 fractions. The GTV ranged from 0.37 to 94.5 cm 3 (mean 13.2 cm 3 , median 5.1 cm 3 ). No evidence of tumor growth was seen on serial imaging in any case.
The mean maximum point dose to the spinal cord in this series for those 22 tumors at the level of the spinal cord was 10 Gy (range 7 to 12 Gy). The mean volume of the spinal cord that received greater than 8 Gy was 0.81 cm 3 (range 0.0 to 5.1 cm 3 ). The mean maximum point dose to the cauda equina for those 18 lesions at the level of the cauda equina was 11 Gy (range 5 to 13 Gy) The mean volume of the cauda equina that received greater than 8 Gy was 1.45 cm 3 (range 0.0 to 10.1 cm 3 ).
A comparison was made between this most recent cohort of 40 cases treating using CBCT image guidance and the first 73 cases of benign tumors treated at our institution. All of these 73 cases had been treated using the CyberKnife Image-Guided Radiosurgery System previously described (46). The mean age of the more recent cohort was older (55 years versus 44 years). The tumor volume of the more recent cohort was slightly larger (13.2 cm 3 versus 10.5 cm 3 ). The mean maximum intratumoral dose was 15.8 Gy in the more recent cohort versus 21.6 Gy. Radiosurgery was used as the primary treatment modality in 55% versus 62% in the prior series and in the post-surgical setting in 55% versus 23% in the prior series (46).
Discussion
Stereotactic body radiosurgery has emerged as a new treatment option in the multidisciplinary management of tumors located within or adjacent (paraspinal) to the vertebral bodies or spinal cord (13, 15-20, 34, 47-54) . Radiosurgery has been documented to be an effective treatment modality for a variety of malignant tumors of the spine and spinal cord (13, (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) . Because the life expectancy of most of these patients with metastatic disease is measured only in months and because radiation injury can take years to manifest (11), there is more controversy regarding radiosurgery for the management of benign tumors of the spine. These are benign tumors that tend to occur in patients with prolonged life expectancies. These lesions are also often intradural, with a close proximity or sometimes contiguous anatomical relationship to the spinal cord or cauda equina. For this reason, the long-term consequences of neural toxicity are of perhaps even greater importance than for patients with metastatic spine disease. Safety is of paramount important.
Open surgical extirpation remains the primary treatment option for benign spinal tumors if feasible. The majority of spinal meningiomas, schwannomas, and neurofibromas are non-infiltrative and can be completely and safely resected using microsurgical techniques (38, (55) (56) (57) . When complete tumor removal is achieved, recurrence is unlikely (35, 38, 58, 59) . In the current series, 55% of cases had demonstrated recurrence after prior open surgical resection. In our previously published experience, only 23% of patients had undergone prior open surgical resection. This may reflect an increase in awareness among referring physicians in the use of radiosurgery as a successful alternative to repeat open surgery in the event of tumor recurrence. However, as we have become more comfortable in the successful clinical outcome of radiosurgery, our more recent experience demonstrates that radiosurgery is still more commonly used as a primary treatment modality.
Radiosurgery represents a great advance in the treatment of both benign and malignant spine tumors. Regardless of the delivery system utilized, in all cases the treatment plan must tightly conform the prescribed dose to the tumor target, while featuring deep dose gradients at the edge and the immediate surrounding normal tissue (60). For spine radiosurgery, the spinal cord and cauda equina are the organs at risk that most frequently limit the prescribed target dose. Spinal cord injury is arguably the most feared complication in radiotherapy and has historically limited the aggressiveness of spinal tumor treatment (61). There has been considerable attention given to attempted determinations of the human and animal radiation tolerance of spinal cord and cauda equina to stereotactic body radiotherapy (47, (62) (63) (64) . Our prescribed dose to the target volume for benign tumors has decreased over time as we have become more comfortable with the successful longterm radiographic control of these lower doses and reinforced as well by the absence of radiation-induced toxicity.
Given their pathological similarities, there is no reason that benign spinal tumors would not be equally as responsive to radiosurgery as their intracranial counterparts (6, 11, 21, (70) (71) (72) (73) (74) . It is for this reason that centers experienced with radiosurgery explored this developing technology to treat benign spine tumors (13, 18) . Multiple publications have now documented both the safety as well as the long-term efficacy of radiosurgery for benign spinal tumors, including 10 year follow-up experience (11, 41) . Similar to intracranial radiosurgery, such clinical experience will support the more widespread adoption of radiosurgery for the treatment of extracranial benign tumors. Radiosurgery will likely radically transform the way that we treat these benign tumors of the spine in the next decade.
In the present study, an attempt was made to examine and evaluate our institution's decade long experience with spine radiosurgery for the treatment of benign tumors. We used as a relative time frame a cohort that was treated after the implementation of CBCT image guidance for spine radiosurgery at our institution in 2007. Such small patient numbers do not lend themselves to valid statistical analysis. Nevertheless, we found that the mean age of the cohort had increased by a decade. We also discovered an increase use in radiosurgery in the post-surgical setting. Perhaps this reflects our preference and comfort to treat recurrent lesions with radiosurgery rather than subjecting patients to the added morbidity and difficulties associated with repeat open surgical extirpation. Finally, with time and greater experience, our prescription doses have gradually decreased as greater knowledge and experience with radiation-induced spinal cord toxicity has developed in the peer-reviewed literature as well as an understanding of spinal cord tolerance to Hypofractionated radiotherapy.
Further clinical experience with radiosurgery for benign tumors of the spine also opens the opportunity for the investigation of the use of radiosurgery for non-neoplastic extracranial indications. Given our current knowledge base regarding the accuracy and conformality of current delivery technologies, combined with our understanding of dose tolerance for the spinal cord and cauda equina and neuroanatomical targets, the next logical step is for the development of "functional" spine radiosurgery. Such benign disease processes might include pain syndromes such as failed back surgery syndrome, reflex sympathetic dystrophy, facet mediated pain, as well as other conditions such as hyperhydrosis and spinal cord injury. While perhaps there has been a trend to lower doses for benign spine tumors with an emphasis on safety, there is no reason that extremely high and highly conformal doses similar to those used for trigeminal neuralgia might not also be employed for the functional ablation of extracranial targets.
Conclusion
Radiosurgery is a safe and clinically effective treatment alternative for benign spinal neoplasms. While surgical extirpation is currently felt to be the best initial treatment option for most benign spinal tumors, spine radiosurgery has been demonstrated to have long-term clinical and radiographic benefit for the treatment of such lesions. In a similar manner in which spine radiosurgery has become a primary treatment option for a variety of intracranial benign tumors, radiosurgery may become the most favorable treatment alternative for similar histologies when found in the spine. The application of radiosurgery for non-neoplastic spine disease deserves future investigation.
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